/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2022-03-30 17:17:542022-04-27 13:08:15Peptilogics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Trial of PLG0206 in Periprosthetic Joint Infection
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2022-03-30 17:07:522022-03-30 17:30:45Peptilogics Receives Award from the Cystic Fibrosis Foundation to Investigate PLG0301 and PLG0206 as Potential Dual-Acting Treatments for Lung Infections Associated with Cystic Fibrosis
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2022-03-22 08:00:412022-04-27 12:48:45Peptilogics’ Presentations at American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting Highlight Peptide Therapeutic PLG0206 for the Treatment of Periprosthetic Joint Infection (PJI)
